| HOME >> MEDICINE >> TECHNOLOGY |
3. Genetic Diseases
a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases Achondroplasia Autosomal Dominant Polycystic Kidney
Disease Cancer Cosmetogenomics Cystic Fibrosis Down's Syndrome Duchenne and Becker Muscular Dystrophy Factor V (Leiden) Factor IX Deficiency Fragile X Syndrome Heart Disease Hemochomatosis Hemophilia Huntington's Disease Maternal-Fetal Incompatibility Multiple Endocrine Neoplasia Phenylketonuria (PKU) Polycystic Kidney Disease (PKD) Prenatal Screening Retinitis Pigmentosa Retinoblastoma Sickle Cell Anemia Spinal Muscular Atrophy Vitamin B12 Metabolism
i. Social Issues and Concerns
4. Forensic Testing
a. Overview
b. Multilocus and Single Locus Probes Multilocus Probes Single Locus Probes PCR and RFLP
c. The FBI
d. DNA Profile Data Banks U.S.A. U.K.
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe
Market Expansion Technology Availability Use of Hair as Evidence
h. Wildlife Forensics
5. Paternity Testing/HLA Typing
6. Other Applications
a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other
H. Competing/complementing Technologies
1. Monoclonal Antibodies/Immunoassays
2. RNA Probes
3. Two-Dimensional Electrophoresis
4. Flow Cytometry
U.S.A.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |